Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEWL and Wound Recurrence Study
NCT02577120Phase 2Active, not recruiting
- Start
- Jan 2019
- Primary completion
- Feb 2029
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of EpiCeram in Chronic wound, burn, diabetic foot ulcer (DFU), pressure ulcer, venous leg ulcer (VLU). Started Jan 2019; status: active, not recruiting.
02
Drugs
EpiCeram
03
Conditions
Chronic woundburndiabetic foot ulcer (DFU)pressure ulcervenous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT02577120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02577120.